Timms G H, Wildsmith E. Reduction of oximes with tervalent titanium, a mild deoximation procedure and the partial synthesis of erythromycylamine[J]. Tetrahedron Lett, 1971,2:195-198.
[2]
孙京国,梁建华,姚国伟,等.克拉霉素的合成进展[J].有机化学,2002,22(12):951-963. Sun Jingguo, Liang Jianhua, Yao Guowei, et al. Progress in synthesis of clarithromycin[J]. Chinese Journal of Organic Chemistry, 2002,22(12):951-963. (in Chinese)
[3]
Morimoto S, Matzunaga T, Adahci T, et al. Erythromycin a derivatives and method for the preparation of the same:Japan, EP 0272110. 1987-01-06.
[4]
梁建华,邓志华,孙京国,等.红霉素A肟羟基的醚化保护[J].北京理工大学报,2003,23(1):120-122. Liang Jianhua, Deng Zhihua, Sun Jingguo, et al. Erherification protection for hysroxyls in erythromycin A oximes[J]. Journal of Beijing Institute of Technology, 2003,23(1):120-122. (in Chinese)
[5]
European Pharmacopoeia Commission. European pharmacopoeia[M].:European Directorate for Quality Medicines, 2008.
[6]
喻剑兵.克拉霉素的合成新方法及杂质分析.杭州:浙江大学,2009. Yu Jianbing. New method and analysis of the impurities in the synthesis of clarithromycin. Hangzhou:Zhejiang University, 2009. (in Chinese)
[7]
国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2010. China Pharmacopoeia Committee. Chinese pharma-copoeia[M]. Beijing:China Medical Science and Technology Publishing House, 2010. (in Chinese)
[8]
郑少军.新型红霉素合成的相关试剂和中间体的研究.北京:北京理工大学生命学院,2004. Zheng Shaojun. The study of reagents and intermediates in the synthesis of new types of erythromycin. Beijing:School of Life Science, Beijing Institute of Technology, 2004. (in Chinese)
[9]
梁建华.克拉霉素的合成:保护技术和区域选择性研究.北京:北京理工大学生命学院,2003. Liang Jianhua. Protection methodologies and regioselec-tivity in the synthesis of clarithro-mycin. Beijing:School of Life Science, Beijing Institute of Technology, 2003. (in Chinese)
